...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

That makes sense, thanks for the response RVXoldtimer!  The trading for ZHCLF has been very spuratic but very tempted to bid for more ;)

Share
New Message
Please login to post a reply